Acupuncture Department, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine/National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Libyan J Med. 2023 Dec;18(1):2251640. doi: 10.1080/19932820.2023.2251640.
Central hiccups following a stroke are a frequent complication, exerting adverse effects on both the stroke condition and the patient's daily life. Existing treatments exhibit limited efficacy and pronounced side effects. Acupuncture has been explored as a supplementary intervention in clinical practice. This study aims to investigate the clinical effectiveness of acupuncture for post-stroke hiccups. To identify published clinical randomized controlled trials addressing post-stroke hiccups treatment, comprehensive searches were conducted across PubMed, the Cochrane Library, EMBASE, Web of Science, Chinese Biological Medical (CBM), Wanfang Database, and China Science and Technology Journal (VIP). In addition, we scrutinized ClinicalTrials.gov and the Chinese Clinical Trial Registry. Employing Cochrane Handbook 5.1.0 and Review Manager 5.4 software, three authors independently reviewed literature, extracted data, and evaluated study quality. Data analysis was performed using Stata 16.0 and Review Manager 5.4. A total of 18 trials were encompassed in the analysis. In comparison to standard treatment, acupuncture exhibited a significant enhancement in treatment effectiveness (RR: 1.27, 95% CI: 1.21-1.33; < 0.00001). Notably, Hiccup Symptom Score displayed a considerable decrease (WMD: -1.28, 95% CI: -1.64 to -0.93; < 0.00001), concurrent with a noteworthy improvement in the quality of life (WMD: 8.470, 95% CI: 7.323-9.617; < 0.00001). Additionally, the incidence of adverse reactions decreased (RR: 0.45, 95% CI: 0.16-1.25; = 0.13), and there was a significant reduction in SAS (WMD: -7.23, 95% CI: -8.47 - -5.99; < 0.00001). Our investigation suggests that acupuncture could prove effective in post-stroke hiccup treatment. Nonetheless, due to concerns about the quality and size of the included studies, conducting higher-quality randomized controlled trials to validate their efficacy is imperative.
中风后出现的中枢性呃逆是一种常见的并发症,对中风病情和患者的日常生活都有不良影响。现有的治疗方法疗效有限,且副作用明显。针刺已被探索作为临床实践中的一种辅助干预措施。本研究旨在探讨针刺治疗中风后呃逆的临床疗效。为了确定已发表的关于中风后呃逆治疗的临床随机对照试验,我们对 PubMed、Cochrane 图书馆、EMBASE、Web of Science、中国生物医学文献数据库(CBM)、万方数据库和中国科技期刊数据库(VIP)进行了全面检索。此外,我们还查阅了 ClinicalTrials.gov 和中国临床试验注册中心。我们使用 Cochrane 手册 5.1.0 和 Review Manager 5.4 软件,由三位作者独立对文献进行了回顾、数据提取和研究质量评估。使用 Stata 16.0 和 Review Manager 5.4 进行数据分析。共纳入 18 项试验进行分析。与标准治疗相比,针刺在治疗效果上有显著提高(RR:1.27,95%CI:1.21-1.33;<0.00001)。值得注意的是,呃逆症状评分显著降低(WMD:-1.28,95%CI:-1.64 至-0.93;<0.00001),同时生活质量显著提高(WMD:8.470,95%CI:7.323-9.617;<0.00001)。此外,不良反应发生率降低(RR:0.45,95%CI:0.16-1.25;=0.13),SAS 评分显著降低(WMD:-7.23,95%CI:-8.47 至-5.99;<0.00001)。我们的研究表明,针刺可能对中风后呃逆的治疗有效。然而,由于对纳入研究的质量和规模存在担忧,开展更高质量的随机对照试验来验证其疗效至关重要。